Peptiva

PEG-MGF

€35,00

ISKLJUČIVO ZA IN VITRO LABORATORIJSKA ISTRAŽIVANJA.
Nije namijenjen osobnoj, kliničkoj, dijagnostičkoj ili veterinarskoj primjeni niti primjeni na ljudima ili životinjama.

Description and specifications

What is PEG-MGF?

PEG-MGF stands for pegylated synthetic peptide related to MGF (mechano growth factor). The offered peptide sequence or fragment should be distinguished from the endogenous IGF-1 variant and its processing in the organism. The exact sequence, binding site, and characteristics of PEG should be confirmed by batch documentation.

Mechanism and Scientific Context

Research on MGF-related sequences encompasses cellular responses to mechanical stimuli. Pegylation can alter the physicochemical properties and behavior of the peptide in an experimental system, but the PEG-MGF designation itself does not prove a specific stability, duration of action, or biological activity.

Main Research Areas

alternative splicing of the IGF-1 gene
mechanotransduction and muscle cell response
satellite cell activation in preclinical models
effect of pegylation on stability and distribution

How to Interpret Research Data?

Evidence is limited and predominantly preclinical. Distinguish between works on IGF-1 variant expression, unpegylated peptides, and specifically characterized pegylated materials; these results are not interchangeable.

Available Peptiva Variants

2 mg · Lyophilized vial
2 mg · Research dispenser

Select an available variant and check its name, total content, and price. The photo is not a substitute for the declaration of the selected variant.

Packaging Format and Content

Research dispenser: The variant contains a fully filled dispenser with the selected content, not just a separate replacement cartridge. The quantity indicated next to the variant refers to the total declared content, not the quantity per individual use.

Lyophilized vial: The variant contains lyophilized material in a vial, without a dispenser. This description does not refer to bacteriostatic water or a separate empty container.

Storage and handling conditions depend on the specific formulation and batch declaration. The packaging form does not confirm sterility, dosing precision, stability, or suitability for human or animal application.

Important Limitations

Evidence for PEG-MGF is limited and mostly preclinical. The product is not intended to enhance athletic performance.

Batch Documentation

For inquiries about available COA documentation, please contact peptivacomhr@gmail.com with the product name and LOT number if known. Availability and scope of analyses are checked for a specific batch. The COA itself does not prove sterility or suitability for human or animal application.

Intended Use and Limitations: The product is intended exclusively for laboratory research. It is not intended for human or animal use, diagnosis, treatment, mitigation, or prevention of disease. The description is not medical advice. The research-use-only label and packaging name do not themselves determine the regulatory status of the product or prove its safety or sterility.

COA on request

To enquire about a certificate of analysis (COA), send the material name, requested variant and LOT / batch number if available. Documents are not published on this page.

Request a COA by email

The button opens your email app with a prepared enquiry. You send the message yourself. peptivacomhr@gmail.com

A COA applies to a specific batch. A purity result alone does not establish sterility, absence of endotoxins or safety for use in humans or animals.